1. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated
with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
2. Chen, Q. & Ames, B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc.
Natl. Acad. Sci. UAS 91, 4130–4134 (1994).
3. Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term
induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
4. Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183–192 (2019).
5. Chan, A. S. L. & Narita, M. Short-term gain, long-term pain: The senescence life cycle and cancer. Genes Dev. 33, 127–143 (2019).
6. Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578–582
(2018).
7. Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472–477 (2016).
8. Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184–189 (2016).
9. Demaria, M. et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7, 165–176
(2017).
10. Simons, J. W. I. M. The use of frequency distributions of cell diameters to characterize cell populations in tissue culture. Exp. Cell
Res. 45, 336–350 (1967).
11. Matsumura, T., Zerrudo, Z. & Hayflick, L. Senescent human diploid cells in culture: Survival. DNA synthesis and morphology. J.
Gerontol. 34, 328–334 (1979).
12. Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685–705 (2013).
13. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010).
14. Huang, K. & Lui, W.-Y. Nectins and Nectin-like molecules (Necls): Recent findings and their role and regulation in spermatogenesis.
Semin. Cell Dev. Biol. 59, 54–61 (2016).
15. Takai, Y. & Nakanishi, H. Nectin and afadin: Novel organizers of intercellular junctions. J. Cell Sci. 116, 17–27 (2003).
16. Noyce, R. S. & Richardson, C. D. Nectin 4 is the epithelial cell receptor for measles virus. Trends Microbiol. 20, 429–439 (2012).
17. Reymond, N. et al. Nectin4/PRR4, a new afadin-associated member of the Nectin family that trans-interacts with Nectin1/PRR1
through V domain interaction. J. Biol. Chem. 276, 43205–43215 (2001).
18. Nagano, T. et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci. Rep. 6, 31758 (2016).
Scientific Reports |
(2023) 13:21602 |
https://doi.org/10.1038/s41598-023-48890-z
13
Vol.:(0123456789)
www.nature.com/scientificreports/
19. Nagano, T. et al. Proline dehydrogenase promotes senescence through the generation of reactive oxygen species. J. Cell Sci. 130,
1413–1420 (2017).
20. Nagano, T. et al. D-amino acid oxidase promotes cellular senescence via the production of reactive oxygen species. Life Sci. Alliance
2, e201800045 (2019).
21. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA
92, 9363–9367 (1995).
22. Kurz, D. J., Decary, S., Hong, Y. & Erusalimsky, J. D. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal
mass during replicative ageing of human endothelial cells. J. Cell Sci. 113, 3613–3622 (2000).
23. Abdrabou, A. & Wang, Z. Post-translational modification and subcellular distribution of Rac1: An update. Cells 7, 263 (2018).
24. Bustelo, X. R., Sauzeau, V. & Berenjeno, I. M. GTP-binding proteins of the Rho/Rac family: Regulation, effectors and functions
in vivo. BioEssays 29, 356–370 (2007).
25. Shekarabi, M. & Kennedy, T. E. The Netrin-1 receptor DCC promotes filopodia formation and cell spreading by activating Cdc42
and Rac1. Mol. Cell. Neurosci. 19, 1–17 (2002).
26. Frank, S. R., Adelstein, M. R. & Hansen, S. H. GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal
adhesion turnover. EMBO J. 25, 1848–1859 (2006).
27. Biran, A. et al. Quantitative identification of senescent cells in aging and disease. Aging Cell 16, 661–671 (2017).
28. Komseli, E.-S. et al. A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor microRNAs and proteins in situ during oncogene-induced senescence. BMC Genomics 19, 37 (2018).
29. Lau, L., Porciuncula, A., Yu, A., Iwakura, Y. & David, G. Uncoupling the senescence-associated secretory phenotype from cell cycle
exit via Interleukin-1 inactivation unveils its protumorigenic role. Mol. Cell. Biol. 39, e00586-e618 (2019).
30. Nakano, M. et al. Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex
I-mediated upregulation of p21 protein. PLoS One 8, e80411 (2013).
31. Fukuhara, T. et al. Activation of Cdc42 by trans interactions of the cell adhesion molecules Nectins through c-Src and Cdc42-GEF
FRG. J. Cell Biol. 166, 393–405 (2004).
32. Sakisaka, T. & Takai, Y. Biology and pathology of nectins and nectin-like molecules. Curr. Opin. Cell Biol. 16, 513–521 (2004).
33. Das, D., Satapathy, S. R., Siddharth, S., Nayak, A. & Kundu, C. N. NECTIN-4 increased the 5-FU resistance in colon cancer cells
by inducing the PI3K–AKT cascade. Cancer Chemother. Pharmacol. 76, 471–479 (2015).
34. Zhang, Y. et al. A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and
tumor growth. Cancer Lett. 375, 179–189 (2016).
35. Pleiman, C. M., Hertz, W. M. & Cambier, J. C. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to
the p85 subunit. Science 263, 1609–1612 (1994).
36. Lu, Y. et al. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
J. Biol. Chem. 278, 40057–40066 (2003).
37. Smart, J. E. et al. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60vsrc) and its normal cellular homologue (pp60c-src). Proc. Natl. Acad. Sci. UAS 78, 6013–6017 (1981).
38. Alessi, D. R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541–6551 (1996).
39. Takano, A. et al. Identification of Nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 69,
6694–6703 (2009).
40. Best, A., Ahmed, S., Kozma, R. & Lim, L. The Ras-related GTPase Rac1 binds tubulin. J. Biol. Chem. 271, 3756–3762 (1996).
41. D’Souza-Schorey, C., Boshans, R. L., McDonough, M., Stahl, P. D. & Van Aelst, L. A role for POR1, a Rac1-interacting protein, in
ARF6-mediated cytoskeletal rearrangements. EMBO J. 16, 5445–5454 (1997).
42. Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. & Ingber, D. E. Geometric control of cell life and death. Science 276,
1425–1428 (1997).
43. Zhu, G. et al. An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis. Oncogene 34, 5971–5982 (2015).
44. Ilić, D. et al. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell
Biol. 143, 547–560 (1998).
45. Jain, N., Iyer, K. V., Kumar, A. & Shivashankar, G. V. Cell geometric constraints induce modular gene-expression patterns via
redistribution of HDAC3 regulated by actomyosin contractility. Proc. Natl. Acad. Sci. USA 110, 11349–11354 (2013).
46. Bao, M., Xie, J., Piruska, A. & Huck, W. T. S. 3D microniches reveal the importance of cell size and shape. Nat. Commun. 8, 1962
(2017).
47. Hodes, R. J. et al. Disease drivers of aging. Ann. N. Y. Acad. Sci. 1386, 45–68 (2016).
48. Collado, M. et al. Tumour biology: Senescence in premalignant tumours. Nature 436, 642 (2005).
49. Challita-Eid, P. M. et al. Enfortumab vedotin antibody-drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in
multiple preclinical cancer models. Cancer Res. 76, 3003–3013 (2016).
50. Sethy, C. et al. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse. J. Cancer
Res. Clin. Oncol. 146, 245–259 (2020).
51. Rosenberg, J. E. et al. Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/
programmed death ligand 1 therapy. J. Clin. Oncol. 37, 2592–2600 (2019).
52. Ginzberg, M. B., Kafri, R. & Kirschner, M. Cell biology. On being the right (cell) size. Science 348, 1245075 (2015).
Acknowledgements
This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers
25640063, 17K15595, 20K07591, 20K15791, and 21K05308, the Uehara Memorial Foundation, Leave a Nest
Grant from Leave a Nest Co., Ltd. and Hyogo Science and Technology Association #4067.
Author contributions
S.K. conceived and designated the experiments. R.K., T.N., T.I., and S.K. performed the experiments. R.K., T.N.,
T.I., and S.K. analyzed the data. R.K., T.N., T.I., and S.K. contributed reagents/materials/analysis tools. R.K., T.N.,
and S.K. wrote the manuscript. All authors reviewed the results and approved the final version of the manuscript.
Competing interests The authors declare no competing interests.
Additional information
Supplementary Information The online version contains supplementary material available at https://doi.org/
10.1038/s41598-023-48890-z.
Scientific Reports |
Vol:.(1234567890)
(2023) 13:21602 |
https://doi.org/10.1038/s41598-023-48890-z
14
www.nature.com/scientificreports/
Correspondence and requests for materials should be addressed to S.K.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2023
Scientific Reports |
(2023) 13:21602 |
https://doi.org/10.1038/s41598-023-48890-z
15
Vol.:(0123456789)
...